Pediatric Rocky Mountain Spotted Fever Clinical Presentation
- Author: Nicholas John Bennett, MBBCh, PhD, MA(Cantab), FAAP; Chief Editor: Russell W Steele, MD more...
The incubation period for Rocky Mountain spotted fever (RMSF) is 2-8 days after the tick bite. A history of tick bite is present in only two thirds of cases.
Symptoms can begin gradually or abruptly. Fever, headache, rash, toxicity, myalgia, and mental confusion are the major clinical manifestations.
The patient's body temperature usually exceeds 38.8°C (101.8°F). Headache is the most common neurologic manifestation. In older children and adults, the headache may be intractable and may be ongoing day and night. Young children may not complain of headache.
Nausea, vomiting, and abdominal pain may occur. Conjunctival hyperemia and photophobia may be observed.
The rash of Rocky Mountain spotted fever is an important pathognomonic feature of the disease and is present in 80-90% of patients. Rash begins as blanching maculopapular lesions. These lesions become petechial or purpuric in approximately one half of patients, accounting for the disease’s former name of black measles.
The rash first appears peripherally on the wrists and ankles. It spreads centripetally over the next 2-3 days. Involvement of the palms and soles is an important diagnostic feature.
In most patients, rash usually appears by the second or third day. However, it may be delayed until the sixth day.
Early recognition of the blanching macular eruption is vital, because the classic petechial rash does not typically appear until 6 days or so after the initial symptoms become apparent.
Body temperature exceeds 38.8°C (101.8°F). The patient may have a toxic appearance. The characteristic skin rash is present in 80-90% of infected individuals. Hepatomegaly and splenomegaly are present in approximately 33% of patients. Signs of meningoencephalitis include restlessness, irritability, mental confusion, and delirium.
Meningismus may occur. Findings may include neck stiffness, photophobia, a positive Kernig sign (pain on knee extension when the hip is flexed to 90°), and a positive Brudzinski sign (knee and hip flexion when the neck is flexed).
Ataxia may be present. Spastic paralysis may occur. Sixth nerve palsy may be observed. Muscle tenderness is a common feature.
Complications may include the following:
Liver impairment with development of jaundice
McQuiston JH, Guerra MA, Watts MR, Lawaczeck E, Levy C, Nicholson WL, et al. Evidence of exposure to spotted fever group rickettsiae among Arizona dogs outside a previously documented outbreak area. Zoonoses Public Health. 2011 Mar. 58(2):85-92. [Medline].
Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006 Mar 31. 55(RR-4):1-27. [Medline]. [Full Text].
Openshaw JJ, Swerdlow DL, Krebs JW, et al. Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg. 2010 Jul. 83(1):174-82. [Medline]. [Full Text].
Centers for Disease Control and Prevention. Rocky Mountain Spotted Fever - Statistics and Epidemiology. Available at http://www.cdc.gov/rmsf/stats/. Accessed: January 27, 2013.
Holman RC, McQuiston JH, Haberling DL, Cheek JE. Increasing incidence of Rocky Mountain spotted fever among the American Indian population in the United States. Am J Trop Med Hyg. 2009 Apr. 80(4):601-5. [Medline].
Adjemian JZ, Krebs J, Mandel E, McQuiston J. Spatial clustering by disease severity among reported Rocky Mountain spotted fever cases in the United States, 2001-2005. Am J Trop Med Hyg. 2009 Jan. 80(1):72-7. [Medline].
Folkema AM, Holman RC, McQuiston JH, Cheek JE. Trends in clinical diagnoses of Rocky Mountain spotted fever among American Indians, 2001-2008. Am J Trop Med Hyg. 2012 Jan. 86(1):152-8. [Medline]. [Full Text].
McQuiston JH, Wiedeman C, Singleton J, Carpenter LR, McElroy K, Mosites E, et al. Inadequacy of IgM antibody tests for diagnosis of Rocky Mountain Spotted Fever. Am J Trop Med Hyg. 2014 Oct. 91 (4):767-70. [Medline].
Maller VG, Agarwal AK, Choudhary AK. Diffusion imaging findings in Rocky Mountain spotted fever encephalitis: a case report. Emerg Radiol. 2012 Jan. 19(1):79-81. [Medline].
Crapp S, Harrar D, Strother M, Wushensky C, Pruthi S. Rocky Mountain spotted fever: 'starry sky' appearance with diffusion-weighted imaging in a child. Pediatr Radiol. 2012 Apr. 42(4):499-502. [Medline].
Centers for Disease Control and Prevention. Rocky Mountain Spotted Fever. Available at http://www.cdc.gov/rmsf/symptoms/index.html#treatment. Accessed: July 22, 2011.
Todd SR, Dahlgren FS, Traeger MS, Beltrán-Aguilar ED, Marianos DW, Hamilton C, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015 May. 166 (5):1246-51. [Medline].
|Organism||Disease or Presentation||Geographic Location|
|Rickettsia rickettsii||Rocky Mountain spotted fever||North, Central and South America|
|Rickettsia conorii||Mediterranean spotted fever, boutonneuse fever, Israeli spotted fever, Astrakhan fever, Indian tick typhus||Europe, Asia, Africa, India, Israel, Sicily, Russia, Europe, Asia, Africa, India, Israel, Sicily, Russia|
|Rickettsia sibirica||Siberian tick typhus, North Asian tick typhus||Siberia, People's Republic of China, Mongolia, Europe|
|Rickettsia australis||Queensland tick typhus||Australia|
|Rickettsia honei||Flinders Island spotted fever, Thai tick typhus||Australia, South Eastern Asia|
|Rickettsia africae||African tick-bite fever||Sub Saharan Africa, Caribbean|
|Rickettsia japonica||Japanese or Oriental spotted fever||Japan|
|Rickettsia felis||Cat flea rickettsiosis, flea borne typhus||Worldwide|
|Rickettsia slovaca||Necrosis, erythema, lymphadenopathy||Europe|
|Rickettsia heilongjaiangensis||Mild spotted fever||China, Asian region of Russia|
|Rickettsia parkeri||Mild spotted fever||US|